ATLX vs AZN · rev $74.4K vs P/E 28, $288.38B cap
Atlas Lithium Corporation Common Stock (ATLX) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
Atlas Lithium Corporation Common Stock (ATLX) is a other industrial metals & mining company listed on US.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Latest reported ATLX revenue for 2026-06-30 was $74.4K. Net income was -$23.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ATLX currently screens at market cap $69.0M.
AZN does not have a complete income-statement cache yet.
ATLX currently screens at market cap $69.0M. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the ATLX and AZN stock pages for the full models.
Not investment advice.